FDMT
USD4D Molecular Therapeutics Inc. Common Stock
$10.500-0.520 (-4.719%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$11.020
最高
$11.020
最低
$10.040
交易量
0.63M
公司基本面
市值
578.4M
行業
生物科技
國家
United States
交易統計
平均交易量
0.80M
交易所
NMS
貨幣
USD
52週範圍
最低 $2.235當前 $10.500最高 $12.34
相關新聞
GlobeNewswire
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global registration Up to $336
查看更多
Analyst Upgrades
RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target
RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics with a Outperform and maintains $26 price target.
查看更多
GlobeNewswire
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。